dc.contributor.author | Galley, Helen F | |
dc.contributor.author | Lowes, Damon A | |
dc.contributor.author | Allen, Lee | |
dc.contributor.author | Cameron, Gary | |
dc.contributor.author | Aucott, Lorna S | |
dc.contributor.author | Webster, Nigel R | |
dc.date.accessioned | 2014-05-02T10:02:01Z | |
dc.date.available | 2014-05-02T10:02:01Z | |
dc.date.issued | 2014-05 | |
dc.identifier.citation | Galley , H F , Lowes , D A , Allen , L , Cameron , G , Aucott , L S & Webster , N R 2014 , ' Melatonin as a potential therapy for sepsis : a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis ' , Journal of Pineal Research , vol. 56 , no. 4 , pp. 427-438 . https://doi.org/10.1111/jpi.12134 | en |
dc.identifier.issn | 0742-3098 | |
dc.identifier.other | PURE: 32906263 | |
dc.identifier.other | PURE UUID: b7712bc6-1c79-4f32-9c6a-72aac402fd93 | |
dc.identifier.other | PubMed: 24650045 | |
dc.identifier.other | Scopus: 84899429649 | |
dc.identifier.other | ORCID: /0000-0001-6277-7972/work/84132258 | |
dc.identifier.uri | http://hdl.handle.net/2164/3237 | |
dc.description | This article is protected by copyright. All rights reserved. This study was funded by the Chief Scientist Office, NHS Scotland. We would like to thank all the volunteers who gave up their time and blood to take part in the study and the data monitoring committee and staff of the intensive care unit for their support. In addition, thanks to Dr Malachy Columb for performing Page's trend test for us and to Annette Fearnley at Nu-Pharm Ltd for her advice. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Pineal Research | en |
dc.rights | CC-BY-NC https://creativecommons.org/licenses/by-nc/3.0/ | en |
dc.subject | sepsis | en |
dc.subject | melatonin | en |
dc.subject | 6-hydroxymelatonin | en |
dc.subject | phase 1 clinical trial | en |
dc.subject | cytokines | en |
dc.subject | R Medicine | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject.lcc | R | en |
dc.title | Melatonin as a potential therapy for sepsis : a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1111/jpi.12134 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=84897347874&partnerID=8YFLogxK | en |